title: Not sold here: limited access to legally available syringes at pharmacies in Tijuana, Mexico.
abstract: BACKGROUND
  Sterile syringe access is a critical component of HIV prevention programs. Although retail pharmacies provide convenient outlets for syringe access, injection drug users (IDUs) may encounter barriers to syringe purchase even where purchase without a prescription is legal. We sought to obtain an objective measure of syringe access in Tijuana, Mexico, where IDUs report being denied or overcharged for syringes at pharmacies.
  
  
  METHODS
  Trained "mystery shoppers" attempted to buy a 1 cc insulin syringe according to a predetermined script at all retail pharmacies in three Tijuana neighborhoods. The same pharmacies were surveyed by telephone regarding their syringe sales policies. Data on purchase attempts were analyzed using basic statistics to obtain an objective measure of syringe access and compared with data on stated sales policies to ascertain consistency.
  
  
  RESULTS
  Only 46 (28.4%) of 162 syringe purchase attempts were successful. Leading reasons for unsuccessful attempts were being told that the pharmacy didn't sell syringes (35.3%), there were no syringes in stock (31.0%), or a prescription was required (20.7%). Of 136 pharmacies also surveyed by telephone, a majority (88.2%) reported selling syringes but only one-third (32.5%) had a successful mystery shopper purchase; the majority of unsuccessful purchases were attributed to being told the pharmacy didn't sell syringes. There was similar discordance regarding prescription policies: 74 pharmacies said in the telephone survey that they did not require a prescription for syringes, yet 10 of these pharmacies asked the mystery shopper for a prescription.
  
  
  CONCLUSIONS
  IDUs in Tijuana have limited access to syringes through retail pharmacies and policies and practices regarding syringe sales are inconsistent. Reasons for these restrictive and inconsistent practices must be identified and addressed to expand syringe access, reduce syringe sharing and prevent HIV transmission.
authors: Division of Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA, USA. rpollini@ucsd.edu.
authors: Robin A
authors: RA
authors: Pollini
authors: Perth C
authors: PC
authors: Rosen
authors: Manuel
authors: M
authors: Gallardo
authors: Brenda
authors: B
authors: Robles
authors: Kimberly C
authors: KC
authors: Brouwer
authors: Grace E
authors: GE
authors: Macalino
authors: Remedios
authors: R
authors: Lozada
references: AIDS Behav. 2010 Jun;14(3):679-87
references: 20300820
references: Lancet. 2008 Nov 15;372(9651):1733-45
references: 18817968
references: Drug Alcohol Depend. 2005 Sep 1;79(3):281-93
references: 16102372
references: J Urban Health. 2006 Mar;83(2):299-307
references: 16736378
references: J Urban Health. 2004 Dec;81(4):661-70
references: 15466847
references: Am J Public Health. 2006 Aug;96(8):1347-53
references: 16809607
references: Public Health Rep. 1998 Jun;113 Suppl 1:81-9
references: 9722813
references: Lancet. 2010 Mar 20;375(9719):1014-28
references: 20189638
references: Subst Use Misuse. 2006;41(5):707-27
references: 16603456
references: J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S46-51
references: 12489615
references: Am J Public Health. 2000 Oct;90(10):1639-40
references: 11030005
references: J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):183-92
references: 11404541
references: J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S26-7
references: 12489609
references: J Urban Health. 2005 Sep;82(3 Suppl 4):iv58-73
references: 16107441
references: PLoS One. 2008 Jul 30;3(7):e2690
references: 18665250
references: Salud Publica Mex. 2007 May-Jun;49(3):165-72
references: 17589770
references: Asia Pac J Public Health. 1988;2(4):245-51
references: 3179107
references: J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S34-9
references: 12489613
references: J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):471-7
references: 16010172
references: J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S40-5
references: 12489614
references: J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):369-76
references: 18176320
references: J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S83-7
references: 12489622
references: J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Sep 1;10(1):82-9
references: 7648290
references: Int J Drug Policy. 2007 Oct;18(5):352-8
references: 17854722
references: Addiction. 2008 Jan;103(1):101-8
references: 18028520
references: BMJ. 1989 Oct 28;299(6707):1076-9
references: 2511969
references: J Psychoactive Drugs. 2005 Sep;37(3):333-9
references: 16295018
references: J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S102-10
references: 9663632
references: Drug Alcohol Depend. 2008 Jan 1;92(1-3):132-40
references: 17714888
references: J Am Pharm Assoc (Wash). 1999 Jan-Feb;39(1):23-6
references: 9990183
references: J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S88-91
references: 12489623